ATPase Inhibitory Factor 1 Antikörper
-
- Target Alle ATPase Inhibitory Factor 1 (ATPIF1) Antikörper anzeigen
- ATPase Inhibitory Factor 1 (ATPIF1)
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser ATPase Inhibitory Factor 1 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
- Produktmerkmale
- Polyclonal Antibody
- Aufreinigung
- Affinity purification
- Immunogen
- Recombinant protein of human ATPIF1
- Isotyp
- IgG
- Top Product
- Discover our top product ATPIF1 Primärantikörper
-
-
- Applikationshinweise
- WB 1:1000-1:5000, IHC 1:50-1:200
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.2 mg/mL
- Buffer
- PBS with 0.05 % sodium azide and 50 % glycerol, PH7.4
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Target
- ATPase Inhibitory Factor 1 (ATPIF1)
- Andere Bezeichnung
- ATPIF1 (ATPIF1 Produkte)
- Hintergrund
- ATPase inhibitor, mitochondrialis anenzymethat in humans is encoded by theATPIF1gene. This gene encodes a mitochondrial ATPase inhibitor. Alternative splicing occurs at this locus and three transcript variants encoding distinct isoforms have been identified. It prevents ATPase from switching to ATP hydrolysis during collapse of the electrochemical gradient, for example during oxygen deprivation ATP synthase inhibitor forms a one to one complex with the F1 ATPase, possibly by binding at the alpha-beta interface. It is thought to inhibit ATP synthesis by preventing the release of ATP. The inhibitor has two oligomeric states, dimer (the active state) and tetramer.
- Molekulargewicht
- 12 kDa
- UniProt
- Q9UII2
-